Akiram Therapeutics
PrivateLast Round
Grant
Nov 24, 2023
Est. Valuation
$12.31M
Total Funding Raised
$570,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Akiram Therapeutics is a biotechnology company that develops innovative and targeted molecular radiotherapy for patients with incurable cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Akiram Therapeutics Comparables
Compare Akiram Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PreTT ApS | 90% | |
| Precirix | 86% | |
| Ariceum Therapeutics | 82% |
Akiram Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 24, 2023 | ||||
| VC Round | Jan 12, 2023 |
Key People
Founding team and executive leadership
Akiram Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Phase2Phase Biopharma | VC Round |
| Sciety | VC Round |
| 3T Invest | VC Round |
| Erling-Persson Foundation | Grant |
| Linc AB | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 34% MoM.
- Oct 4, 2025
Attending EANM Congress 2025 in Barcelona from October 4-8.
Recent news
Latest coverage and updates
- partners_withAug 20, 2026
Akiram Therapeutics partnered with ITM SE on Aug 20th '26.
Akiram Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Akiram Therapeutics's valuation, stock price, and market status.
Is Akiram Therapeutics a public or private company?
Akiram Therapeutics is a private company.
What is the current stock price of Akiram Therapeutics?
Akiram Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Akiram Therapeutics worth (valuation)?
Akiram Therapeutics's valuation is estimated at $12.3M based on funding round data.
Can I buy Akiram Therapeutics stock?
Akiram Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Akiram Therapeutics's last funding round?
Akiram Therapeutics's most recent funding round was Grant on January 12, 2023.
Who are the main investors in Akiram Therapeutics?
Key investors in Akiram Therapeutics include Sciety.
Will Akiram Therapeutics IPO soon?
No public IPO plans have been announced for Akiram Therapeutics.
How can I track Akiram Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Akiram Therapeutics's secondary market activity and sign up for updates.